Odonate, Inc. (ODTC)

Odonate Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Selling, General & Admin	9.4	10.39	10.9	10.82	4.84	0.46
Research & Development	71.28	117.04	104.03	79.95	27.9	2.62
Operating Expenses	80.68	127.43	114.93	90.76	32.74	3.09
Operating Income	-80.68	-127.43	-114.93	-90.76	-32.74	-3.09
Interest & Investment Income	-	-	-	1.8	-	-
Other Non Operating Income (Expenses)	0.37	1.17	3.11	-	-	-
EBT Excluding Unusual Items	-80.31	-126.27	-111.83	-88.96	-32.74	-3.09
Gain (Loss) on Sale of Assets	-0.11	-0.08	-	-	-	-
Pretax Income	-102.07	-126.35	-111.83	-88.96	-32.74	-3.09
Net Income	-102.07	-126.35	-111.83	-88.96	-32.74	-3.09
Net Income to Common	-102.07	-126.35	-111.83	-88.96	-32.74	-3.09
Free Cash Flow	-94.58	-113.56	-96.8	-69	-25.94	-1.73
EBITDA	-80.18	-126.99	-114.5	-90.41	-32.72	-
D&A For EBITDA	0.5	0.45	0.43	0.35	0.02	-
EBIT	-80.68	-127.43	-114.93	-90.76	-32.74	-3.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.